RU2018133333A3 - - Google Patents

Download PDF

Info

Publication number
RU2018133333A3
RU2018133333A3 RU2018133333A RU2018133333A RU2018133333A3 RU 2018133333 A3 RU2018133333 A3 RU 2018133333A3 RU 2018133333 A RU2018133333 A RU 2018133333A RU 2018133333 A RU2018133333 A RU 2018133333A RU 2018133333 A3 RU2018133333 A3 RU 2018133333A3
Authority
RU
Russia
Application number
RU2018133333A
Other versions
RU2730870C2 (ru
RU2018133333A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018133333A publication Critical patent/RU2018133333A/ru
Publication of RU2018133333A3 publication Critical patent/RU2018133333A3/ru
Application granted granted Critical
Publication of RU2730870C2 publication Critical patent/RU2730870C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2018133333A 2016-02-25 2017-02-27 Композиции и способы для профилактики и/или лечения недостатка витамина в12 RU2730870C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2016323 2016-02-25
NL2016323 2016-02-25
PCT/NL2017/050119 WO2017146580A1 (en) 2016-02-25 2017-02-27 Compositions and methods for preventing and/or treating vitamin b12 deficiency

Publications (3)

Publication Number Publication Date
RU2018133333A RU2018133333A (ru) 2020-03-25
RU2018133333A3 true RU2018133333A3 (ru) 2020-03-25
RU2730870C2 RU2730870C2 (ru) 2020-08-26

Family

ID=56507778

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018133333A RU2730870C2 (ru) 2016-02-25 2017-02-27 Композиции и способы для профилактики и/или лечения недостатка витамина в12

Country Status (12)

Country Link
US (1) US10857189B2 (ru)
EP (1) EP3419637B1 (ru)
JP (2) JP7012651B2 (ru)
KR (1) KR20180113535A (ru)
CN (1) CN108697742A (ru)
AU (1) AU2017222990A1 (ru)
BR (1) BR112018017233A2 (ru)
CA (1) CA3014525A1 (ru)
ES (1) ES2865477T3 (ru)
RU (1) RU2730870C2 (ru)
SG (1) SG11201807023QA (ru)
WO (1) WO2017146580A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2551642B (en) 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2017146580A1 (en) 2016-02-25 2017-08-31 Caelus Pharmaceuticals B.V. Compositions and methods for preventing and/or treating vitamin b12 deficiency
KR20180133443A (ko) * 2016-04-11 2018-12-14 바게닝겐 유니버시테이트 신규한 세균 종
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CA3106315A1 (en) * 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
US9433650B2 (en) * 2011-08-30 2016-09-06 Academisch Medisch Centrum Method for preventing and/or treating insulin resistance
AU2012315956B2 (en) 2011-09-29 2016-01-21 Seagen Inc. Intact mass determination of protein conjugated agent compounds
US20140242654A1 (en) 2013-02-26 2014-08-28 Coskata, Inc. Butyrate Producing Clostridium species, Clostridium pharus
US9669059B2 (en) 2013-03-15 2017-06-06 University Of Florida Research Foundation, Incorporated Butyrogenic bacteria as probiotics to treat clostridium difficile
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
DK3242957T3 (da) 2015-01-09 2020-06-02 Univ Wageningen Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme
RU2737398C1 (ru) 2015-12-31 2020-11-30 Калус Фармасьютикалс Б.В. Способ культивирования и сохранения eubacterium hallii
WO2017146580A1 (en) 2016-02-25 2017-08-31 Caelus Pharmaceuticals B.V. Compositions and methods for preventing and/or treating vitamin b12 deficiency

Also Published As

Publication number Publication date
JP2022031800A (ja) 2022-02-22
WO2017146580A1 (en) 2017-08-31
KR20180113535A (ko) 2018-10-16
CA3014525A1 (en) 2017-08-31
JP2019506413A (ja) 2019-03-07
JP7012651B2 (ja) 2022-01-28
BR112018017233A2 (pt) 2019-01-15
US20190038678A1 (en) 2019-02-07
CN108697742A (zh) 2018-10-23
JP7219801B2 (ja) 2023-02-08
EP3419637B1 (en) 2021-01-27
RU2730870C2 (ru) 2020-08-26
ES2865477T3 (es) 2021-10-15
AU2017222990A1 (en) 2018-09-20
RU2018133333A (ru) 2020-03-25
EP3419637A1 (en) 2019-01-02
US10857189B2 (en) 2020-12-08
SG11201807023QA (en) 2018-09-27

Similar Documents

Publication Publication Date Title
RU2018133333A3 (ru)
JP1607778S (ru)
JP1579283S (ru)
JP1584320S (ru)
JP1573548S (ru)
JP1563528S (ru)
JP1566505S (ru)
JP1557196S (ru)
CN303549124S (ru)
CN303545344S (ru)
CN303549503S (ru)
CN303549185S (ru)
CN303543869S (ru)
CN303548712S (ru)
CN303548544S (ru)
CN303548464S (ru)
CN303548364S (ru)
CN303547385S (ru)
CN303549919S (ru)
CN303546742S (ru)
CN303546738S (ru)
CN303546240S (ru)
CN303546185S (ru)
CN303545283S (ru)
CN303545102S (ru)